A health technology assessment (HTA) is undertaken focusing on primary screening, screening for complications, pharmacological and non-pharmacological treatment of diabetes type II. The HTA focuses primarily on the efficacy and the cost-effectiveness of the procedures. Participants in the project: DSI and DACEHTA. CEMTV rapport
Danish Institute for Health Services Research
Record ID 32005000592
Danish
Details
Project Status:
Completed
URL for project:
http://www.dsi.dk/
Year Published:
2003
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Denmark
MeSH Terms
- Cost-Benefit Analysis
- Diabetes Mellitus, Type 2
- Hypoglycemic Agents
Contact
Organisation Name:
Danish Institute for Health Services Research
Contact Address:
DSI, PO Box 2595, 2100 Copenhagen, Denmark Tel: +45 35 29 8400; Fax: +45 35 29 8499
Contact Name:
hhj@dsi.dk
Contact Email:
hhj@dsi.dk
Copyright:
Danish Institute for Health Services Research (DSI)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.